Reversion From Chronic Migraine to Episodic Migraine After Erenumab Treatment
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Cephalalgia: An International Journal of Headache
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Reversion From Chronic Migraine to Episodic Migraine Following Treatment With Erenumab: Results of a Post-Hoc Analysis of a Randomized, 12-Week, Double-Blind Study and a 52-Week, Open-Label Extension
Cephalalgia 2021 Jan 01;41(1)6-16, RB Lipton, SJ Tepper, SD Silberstein, D Kudrow, M Ashina, U Reuter, DW Dodick, F Zhang, GA Rippon, S Cheng, DD MikolFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.